Search research articles
Contact Us
Filters
Showing results (281-290 of 386) with videos related to
Page
of 39
Sort By:
International Journal of Cancer
|
March 14, 2013
Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial
Alaa M Ali, Elena Provenzano, John M S Bartlett, et al.
The Journal of Pathology
|
November 16, 2012
Authors' reply
Melanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
British Journal of Cancer
|
August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial
J M S Bartlett, T O Nielsen, D Gao, et al.
The American Journal of Surgical Pathology
|
October 7, 2017
Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis
Rola M Saleeb, Fadi Brimo, Mina Farag, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue
Pauline J Carder, Claire E Murphy, Peter Dervan, et al.
British Journal of Cancer
|
April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients
Walead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
July 20, 2019
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture
Alexander E G Baker, Laura C Bahlmann, Roger Y Tam, et al.
Cancers
|
May 27, 2026
Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance
Soo Jin Seung, Jane Bayani, Lena Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study
Vicky S Sabine, Cheryl Crozier, Cassandra L Brookes, et al.
Breast Cancer Research : BCR
|
February 8, 2016
Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer
Marsela Braunstein, Linda Liao, Nicola Lyttle, et al.
Page
of 39
Search research articles
Search
Showing results (281-290 of 386) with videos related to
Sort By:
Page
of 39
International Journal of Cancer
|
March 14, 2013
Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial
Alaa M Ali, Elena Provenzano, John M S Bartlett, et al.
The Journal of Pathology
|
November 16, 2012
Authors' reply
Melanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
British Journal of Cancer
|
August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial
J M S Bartlett, T O Nielsen, D Gao, et al.
The American Journal of Surgical Pathology
|
October 7, 2017
Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis
Rola M Saleeb, Fadi Brimo, Mina Farag, et al.
Breast Cancer Research and Treatment
|
September 13, 2005
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue
Pauline J Carder, Claire E Murphy, Peter Dervan, et al.
British Journal of Cancer
|
April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients
Walead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
July 20, 2019
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture
Alexander E G Baker, Laura C Bahlmann, Roger Y Tam, et al.
Cancers
|
May 27, 2026
Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance
Soo Jin Seung, Jane Bayani, Lena Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study
Vicky S Sabine, Cheryl Crozier, Cassandra L Brookes, et al.
Breast Cancer Research : BCR
|
February 8, 2016
Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer
Marsela Braunstein, Linda Liao, Nicola Lyttle, et al.
Page
of 39